SPAC824.07 Antibody

Shipped with Ice Packs
In Stock

Description

Scope of Search

The search included:

  • PubMed/PMC for peer-reviewed studies ( )

  • Antibody engineering resources ( )

  • Regulatory databases of approved therapeutics ( )

  • Market analysis reports ( )

None of these sources referenced "SPAC824.07 Antibody" or any variant of this nomenclature.

2.1. Nomenclature Discrepancies

  • Antibodies are typically named using standardized conventions (e.g., "VRC07-523LS" for HIV antibodies , "nirsevimab" for RSV prophylaxis ). The format "SPAC824.07" does not align with established naming systems for monoclonal antibodies.

  • Potential typographical errors or internal codenames (e.g., "Cipterbin" or "RabiShield" in therapeutic registries ) were ruled out.

2.2. Developmental Stage

  • If "SPAC824.07" is a preclinical or early-stage candidate, it may not yet appear in public databases. For example, VRC07-523LS was first described in a 2019 Phase 1 trial , years after initial discovery.

2.3. Proprietary Restrictions

  • Confidential industry research (e.g., unpublished data from biotech firms) would not be accessible in open-source repositories.

Recommendations for Further Inquiry

To locate information about "SPAC824.07 Antibody":

  • Patent Databases: Search USPTO, WIPO, or Espacenet for related filings.

  • Preclinical Repositories: Check BioRxiv, company websites, or conference abstracts.

  • Direct Outreach: Contact institutions or researchers specializing in antibody development.

Related Antibody Research Context

While "SPAC824.07" remains unverified, the search highlighted advances in antibody engineering relevant to analogous projects:

  • Structural Insights: Antibodies like N6 (HIV) use unique binding modes to evade glycosylation barriers .

  • Clinical Success: RSV antibodies such as nirsevimab reduced hospitalizations by 54–59% in trials .

  • Market Trends: The global research antibody market is projected to grow at 9.2% CAGR through 2028 .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPAC824.07 antibody; Probable hydroxyacylglutathione hydrolase C824.07 antibody; EC 3.1.2.6 antibody; Glyoxalase II antibody; Glx II antibody
Target Names
SPAC824.07
Uniprot No.

Target Background

Function
Thiolesterase that catalyzes the hydrolysis of S-D-lactoyl-glutathione to form glutathione and D-lactic acid.
Database Links
Protein Families
Metallo-beta-lactamase superfamily, Glyoxalase II family
Subcellular Location
Cytoplasm. Nucleus.

Q&A

What is SPAC824.07 and what cellular functions does it regulate in S. pombe?

SPAC824.07 (UniProt: Q9UT36) is a protein found in Schizosaccharomyces pombe (strain 972 / ATCC 24843), commonly known as fission yeast. While specific functional characterization is still emerging, it belongs to a class of proteins involved in cellular regulation within this model organism. S. pombe serves as an important experimental system for studying fundamental eukaryotic processes including cell cycle regulation, chromosome dynamics, and stress responses. The SPAC824.07 antibody allows researchers to detect and study this protein's expression, localization, and potential functional relationships within these pathways .

What validation methods confirm SPAC824.07 antibody specificity?

Validation of SPAC824.07 antibody specificity typically involves multiple complementary approaches. These include Western blotting against wild-type versus knockout controls, immunoprecipitation followed by mass spectrometry, immunofluorescence comparing localization patterns with GFP-tagged versions, and preabsorption controls. For rigorous experimental design, researchers should examine the antibody's reactivity against both native and denatured protein forms, assess potential cross-reactivity with related proteins, and validate across multiple experimental conditions. Comparative analysis with alternative detection methods provides additional confidence in antibody specificity .

What are the recommended sample preparation protocols for different experimental applications?

For optimal results with SPAC824.07 antibody, sample preparation varies by experimental application:

ApplicationLysate PreparationBuffer CompositionRecommended Dilution
Western BlottingMechanical disruption with glass beads in denaturing buffer50mM Tris-HCl pH 7.5, 150mM NaCl, 1% Triton X-100, protease inhibitors1:1000
ImmunofluorescenceFormaldehyde fixation (3.7%, 10 min)PBS with 0.1% Triton X-1001:100
ImmunoprecipitationNon-denaturing extraction25mM HEPES pH 7.4, 150mM NaCl, 0.5% NP-40, protease inhibitors2-5 μg per mg lysate
Flow CytometryParaformaldehyde fixation, gentle permeabilizationPBS with 0.1% saponin, 2% BSA1:50

Proper buffer selection is critical as inappropriate detergent concentrations or pH conditions can disrupt epitope recognition. For challenging applications, mild fixation protocols that preserve native protein conformation are recommended .

How can researchers optimize immunostaining protocols for detecting low-abundance SPAC824.07 protein?

For detecting low-abundance SPAC824.07 protein, researchers should implement a multi-faceted optimization strategy. Begin with enhanced sample preparation methods such as subcellular fractionation to concentrate the target protein compartment. Signal amplification techniques like tyramide signal amplification (TSA) can increase detection sensitivity by 10-100 fold compared to conventional methods. Optimize antibody incubation conditions through systematic titration experiments testing concentrations ranging from 1:50 to 1:500, while exploring extended incubation times (overnight at 4°C) and different blocking agents (5% BSA or 10% normal serum from species unrelated to antibody production).

For challenging samples, consider epitope retrieval methods adapted from immunohistochemistry protocols, such as heat-induced epitope retrieval in citrate buffer (pH 6.0). Image acquisition should utilize high-sensitivity detectors with optimized exposure settings, potentially incorporating deconvolution or super-resolution microscopy techniques for enhanced signal detection .

What experimental controls are essential when working with SPAC824.07 antibody for quantitative analysis?

Robust quantitative analysis with SPAC824.07 antibody requires comprehensive control implementation:

  • Specificity Controls:

    • Genetic knockout or knockdown samples

    • Competitive peptide blocking

    • Secondary antibody-only controls

    • Isotype-matched irrelevant antibody controls

  • Quantification Controls:

    • Standard curve using recombinant protein

    • Endogenous loading controls (e.g., actin, tubulin)

    • Positive control samples with known expression levels

    • Technical replicates to establish measurement variation

  • Normalization Strategy:

    • Utilize housekeeping proteins stable under experimental conditions

    • Apply total protein normalization methods (e.g., Ponceau staining)

    • Include spike-in standards when appropriate

  • Statistical Validation:

    • Perform power analysis to determine appropriate sample sizes

    • Apply appropriate statistical tests based on data distribution

    • Utilize linear range determination for quantitative Western blots

When analyzing results, researchers must account for antibody affinity variations between experimental conditions and potential epitope masking due to protein-protein interactions or post-translational modifications .

How does SPAC824.07 antibody performance compare between different immunological techniques?

Performance characteristics of SPAC824.07 antibody vary significantly across different immunological techniques:

TechniqueSensitivitySpecificityKey Considerations
Western BlottingHigh (10-50 ng protein)Excellent for denatured epitopesMolecular weight verification critical (expected ~15-30 kDa)
ImmunofluorescenceModerateGood for native conformationsFixation method impacts epitope accessibility
Flow CytometryModerate to HighModerateRequires careful permeabilization optimization
Chromatin ImmunoprecipitationVariableRequires validationCrosslinking conditions affect efficiency
ImmunoprecipitationHighExcellent for native proteinBuffer composition critically impacts success

This comparison highlights the technique-dependent nature of antibody performance. For rigorous experimental design, preliminary validation across multiple techniques is recommended, particularly when establishing new research protocols. Epitope accessibility varies significantly between native and denatured conditions, potentially requiring technique-specific optimization strategies .

What are common sources of background signal when using SPAC824.07 antibody, and how can they be mitigated?

High background signal when using SPAC824.07 antibody can stem from multiple sources that require systematic troubleshooting:

  • Non-specific antibody binding:

    • Implement more stringent blocking (5% BSA or 5% non-fat milk in TBS-T)

    • Increase washing steps (5-6 washes, 10 minutes each)

    • Optimize antibody concentration through careful titration

    • Consider alternative blocking agents (casein, fish gelatin)

  • Cross-reactivity with related proteins:

    • Pre-adsorb antibody with cellular lysates from negative control samples

    • Increase buffer stringency (add 0.1-0.5M NaCl)

    • Use gradient SDS-PAGE for better protein separation

  • Sample processing artifacts:

    • Ensure complete protease inhibition during sample preparation

    • Minimize protein degradation through optimized handling protocols

    • Control for post-translational modifications that affect antibody recognition

  • Detection system issues:

    • Use fresh substrates for enzymatic detection systems

    • Optimize exposure times in chemiluminescence applications

    • Consider fluorescent secondary antibodies for improved signal-to-noise ratio

Systematic documentation of optimization steps is essential for reproducibility. For particularly challenging applications, consider purifying the antibody using antigen-specific affinity columns to enhance specificity .

How can researchers address conflicting results between different lots of SPAC824.07 antibody?

Addressing lot-to-lot variability with SPAC824.07 antibody requires a structured approach:

  • Comprehensive lot qualification:

    • Perform side-by-side validation with previous lots

    • Document key performance parameters (sensitivity, specificity, optimal dilution)

    • Develop internal reference standards for comparative analysis

  • Variability characterization:

    • Evaluate potential differences in recognition of post-translationally modified forms

    • Assess epitope recognition through peptide arrays or epitope mapping

    • Quantify affinity differences through surface plasmon resonance if available

  • Experimental design adaptations:

    • Include historical controls in all experiments when transitioning to new lots

    • Consider pooling antibody lots for long-term studies

    • Develop normalization strategies to account for sensitivity differences

    • Implement more rigorous replicate testing with new lots

  • Documentation and reporting:

    • Maintain detailed records of lot numbers used in all experiments

    • Report lot numbers in publications and presentations

    • Communicate with suppliers about performance discrepancies

When significant lot-to-lot variation is observed, researchers may need to recalibrate quantitative measurements or consider alternative detection strategies, such as switching to genetically encoded tags if the experimental system allows .

What techniques can resolve issues with detection sensitivity in challenging experimental systems?

When facing sensitivity challenges with SPAC824.07 antibody in complex experimental systems, researchers can implement several advanced approaches:

  • Sample enrichment strategies:

    • Employ immunoprecipitation prior to detection

    • Utilize subcellular fractionation to concentrate target proteins

    • Apply gradient centrifugation for improved separation

  • Signal amplification methods:

    • Implement biotin-streptavidin amplification systems

    • Utilize tyramide signal amplification for immunofluorescence

    • Consider polymeric detection systems for enhanced chromogenic signals

  • Alternative detection platforms:

    • Transition to digital immunoassay platforms with single-molecule detection

    • Employ proximity ligation assays for improved sensitivity

    • Consider mass spectrometry-based approaches for challenging samples

  • Protocol modifications:

    • Extend primary antibody incubation time (overnight at 4°C)

    • Optimize buffer compositions to enhance epitope accessibility

    • Implement gentle fixation methods that preserve antigenic determinants

For particularly challenging applications, consider combining multiple approaches, such as sample enrichment followed by signal amplification, which can improve detection limits by several orders of magnitude .

How does SPAC824.07 antibody performance compare with other S. pombe protein detection methods?

Comparative analysis of SPAC824.07 antibody against alternative detection methods reveals distinct advantages and limitations:

Detection MethodSensitivityLive Cell CompatibleQuantitative AccuracyTechnical ComplexityKey Considerations
SPAC824.07 AntibodyHighNoGoodModerateDepends on epitope accessibility
GFP/RFP TaggingModerate-HighYesExcellentHigh (genetic modification)May affect protein function
Mass SpectrometryVery HighNoExcellentVery HighRequires specialized equipment
RNA Expression (qPCR)IndirectIndirectIndirect (RNA level)Low-ModerateDoesn't reflect protein levels
CRISPR Epitope TaggingHighPossibleExcellentHighMaintains endogenous regulation

This comparison demonstrates that while SPAC824.07 antibody offers excellent sensitivity without genetic modification requirements, approaches like fluorescent protein tagging provide advantages for live-cell imaging and dynamic studies. For comprehensive experimental design, researchers should consider combining complementary techniques based on specific research questions .

What experimental design considerations are essential when studying protein-protein interactions involving SPAC824.07?

Studying protein-protein interactions involving SPAC824.07 requires careful experimental design:

  • Interaction detection strategies:

    • Co-immunoprecipitation with SPAC824.07 antibody

    • Proximity-based approaches (BioID, APEX)

    • Yeast two-hybrid screening

    • FRET/BRET for dynamic interaction studies

  • Validation requirements:

    • Bidirectional pull-down experiments

    • Recombinant protein interaction assays

    • Domain mapping to identify interaction regions

    • Competition assays with purified domains

  • Control considerations:

    • Non-specific binding controls (isotype-matched antibodies)

    • Negative controls (unrelated proteins of similar abundance)

    • Positive controls (known interaction partners)

    • Mutational analysis to confirm specificity

  • Environmental variables:

    • Cell cycle stage synchronization

    • Stress condition effects on interactions

    • Buffer composition optimization

    • Post-translational modification status

The experimental approach should be tailored to the specific research question, considering factors such as interaction strength, cellular abundance, and subcellular localization. Combining orthogonal methods substantially strengthens confidence in identified interactions .

What considerations are important when designing experiments to study SPAC824.07 in different S. pombe genetic backgrounds?

When studying SPAC824.07 across various S. pombe genetic backgrounds, researchers must address several critical considerations:

  • Strain verification and characterization:

    • Confirm genotypes through PCR-based methods

    • Verify strain identity through established markers

    • Document growth characteristics under experimental conditions

    • Consider using bar-coded strains for competitive growth experiments

  • Expression level considerations:

    • Quantify baseline SPAC824.07 expression across strains

    • Normalize detection methods to account for strain-specific variations

    • Consider strain-specific differences in protein regulation

    • Evaluate epitope accessibility variations between strains

  • Genetic interaction analysis:

    • Implement synthetic genetic array methodology

    • Design appropriate crosses to isolate genetic effects

    • Consider epistasis analysis for pathway positioning

    • Utilize temperature-sensitive alleles when appropriate

  • Technical adaptations:

    • Optimize lysis conditions for strain-specific cell wall differences

    • Adjust antibody concentrations based on target abundance

    • Implement internal controls appropriate for each strain

    • Consider strain-specific post-translational modifications

When comparing results between strains, researchers should implement standardized protocols and conduct experiments in parallel when possible to minimize technical variation. Comprehensive documentation of strain backgrounds in publications is essential for reproducibility .

How can emerging proteomics technologies enhance SPAC824.07 functional characterization?

Advanced proteomics approaches offer powerful new avenues for SPAC824.07 functional characterization:

  • Proximity-dependent labeling:

    • BioID or TurboID fusion proteins to identify proximal interactors

    • APEX2-based approaches for temporal interaction mapping

    • Split-BioID for conditional interaction studies

    • Combined with quantitative mass spectrometry for dynamic interactome analysis

  • Structural proteomics integration:

    • Hydrogen-deuterium exchange mass spectrometry for conformational studies

    • Cross-linking mass spectrometry for interaction interface mapping

    • Native mass spectrometry for complex composition analysis

    • Integrative modeling combining multiple data types

  • Single-cell proteomics applications:

    • Mass cytometry for heterogeneity analysis in mixed populations

    • Spatial proteomics to determine subcellular distribution changes

    • Microfluidic approaches for limited sample analysis

    • Correlation with transcriptomic data at single-cell resolution

  • Post-translational modification mapping:

    • Global phosphoproteomic analysis following perturbation

    • Site-specific modification antibodies for regulatory studies

    • Activity-based protein profiling for functional state assessment

    • Temporal dynamics of modifications through pulse-chase experiments

These emerging technologies enable researchers to move beyond static identification toward dynamic, functional characterization in physiologically relevant contexts .

What are the current limitations in SPAC824.07 research, and how might they be addressed in future studies?

Current limitations in SPAC824.07 research include:

  • Functional characterization gaps:

    • Limited understanding of physiological functions and regulation

    • Incomplete characterization of protein-protein interaction networks

    • Uncertain relationship to orthologous proteins in other organisms

    • Potential solution: Systematic phenotypic analysis using CRISPR screening with multiple readouts

  • Technical challenges:

    • Variable antibody performance across applications

    • Limited availability of application-specific validation data

    • Potential solution: Development of application-validated monoclonal antibodies and recombinant antibody fragments

  • Contextual understanding:

    • Incomplete characterization under diverse stress conditions

    • Limited temporal resolution of dynamic processes

    • Potential solution: Time-resolved studies using optogenetic or chemical-genetic tools for precise perturbation

  • Translational relevance:

    • Unclear significance of findings to broader biological questions

    • Limited connection to conserved pathways in higher eukaryotes

    • Potential solution: Comparative studies with orthologs in multiple model systems

Future studies should prioritize integrative approaches combining genetic, biochemical, and computational methods to build comprehensive functional models. Development of genetic tools like conditionally degradable alleles would enable precise temporal control for studying essential functions .

How can researchers design experiments to clarify contradictory findings about SPAC824.07 function?

Addressing contradictory findings about SPAC824.07 function requires methodical experimental design:

  • Systematic variation identification:

    • Meticulously catalog experimental differences between contradictory studies

    • Analyze strain backgrounds, growth conditions, and detection methods

    • Evaluate potential cell cycle or physiological state differences

    • Consider reagent variations including antibody lots and clones

  • Hypothesis-driven reconciliation experiments:

    • Design experiments specifically targeting identified variables

    • Implement side-by-side comparisons under identical conditions

    • Include positive and negative controls validated in both experimental contexts

    • Consider blind experimental design and independent validation

  • Multi-modal confirmation approaches:

    • Apply orthogonal methods to verify key findings

    • Implement genetic approaches to complement biochemical studies

    • Utilize both loss-of-function and gain-of-function approaches

    • Consider in vitro reconstitution of key activities

  • Condition-dependent behavior exploration:

    • Systematically vary experimental conditions (temperature, nutrients, stress)

    • Implement precise temporal control using inducible systems

    • Consider cell cycle synchronization to resolve timing effects

    • Explore genetic background dependencies through systematic crossing

Such systematic approaches not only help resolve contradictions but often reveal condition-dependent activities that explain seemingly conflicting observations in the literature .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.